Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 9Rhabdomyosarcoma 5Wilms Tumor 2Ovarian Neoplasms 2Melanoma 2Malignant mesenchymal tumor 2Gestational Trophoblastic Disease 2Fibrosarcoma 2Testicular Neoplasms 1Teratoma, Ovarian 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Germ Cell and Embryonal 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Filgrastim 9Ifosfamide 8Etoposide 8Doxorubicin 8Cyclophosphamide 8Vincristine 7X-Rays 6Radiotherapy 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Topotecan 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Irinotecan 4Biopsy 4Thiotepa 3Imatinib Mesylate 3Carboplatin 3Bevacizumab 3ulixertinib 2tipifarnib 2temsirolimus 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroectodermal Tumors, Primitive, Peripheral × Dactinomycin × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡